177 related articles for article (PubMed ID: 26168763)
41. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
Caulkins JP; Tragler G; Wallner D
Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
[TBL] [Abstract][Full Text] [Related]
42. Understanding post 9/11 drug control policy and politics in Central Asia.
Latypov A
Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
[TBL] [Abstract][Full Text] [Related]
43. Evaluating national harm reduction programs.
Des Jarlais DC
Addiction; 2005 Nov; 100(11):1575-6. PubMed ID: 16277620
[No Abstract] [Full Text] [Related]
44. Malaysia and harm reduction: the challenges and responses.
Reid G; Kamarulzaman A; Sran SK
Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
[TBL] [Abstract][Full Text] [Related]
45. Distribution of opium coupons to addicts in Iran: policies and problems.
Siassi I; Fozouni B
Chem Depend; 1980; 4(1-2):127-33. PubMed ID: 7226284
[No Abstract] [Full Text] [Related]
46. Crystal in Iran: methamphetamine or heroin kerack.
Alam Mehrjerdi Z
Daru; 2013 Mar; 21(1):22. PubMed ID: 23497450
[TBL] [Abstract][Full Text] [Related]
47. Living with addiction: the perspectives of drug using and non-using individuals about sharing space in a hospital setting.
Strike C; Guta A; de Prinse K; Switzer S; Chan Carusone S
Int J Drug Policy; 2014 May; 25(3):640-9. PubMed ID: 24679487
[TBL] [Abstract][Full Text] [Related]
48. The establishment of a methadone treatment clinic for women in Tehran, Iran.
Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Mokri A
J Public Health Policy; 2011 May; 32(2):219-30. PubMed ID: 21390074
[TBL] [Abstract][Full Text] [Related]
49. The children of mama coca: coca, cocaine and the fate of harm reduction in South America.
Bastos FI; Caiaffa W; Rossi D; Vila M; Malta M
Int J Drug Policy; 2007 Mar; 18(2):99-106. PubMed ID: 17689352
[TBL] [Abstract][Full Text] [Related]
50. Bangkok 2004. The spread of harm-reduction programs in Brazil.
Teixeira LP
HIV AIDS Policy Law Rev; 2004 Dec; 9(3):94-5. PubMed ID: 15812931
[TBL] [Abstract][Full Text] [Related]
51. How the harm reduction movement contrasts itself against punitive prohibition.
Tammi T; Hurme T
Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
[TBL] [Abstract][Full Text] [Related]
52. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
53. Drug injecting and HIV infection among the population of drug abusers in Asia.
Poshyachinda V
Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
[TBL] [Abstract][Full Text] [Related]
54. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
Sobeyko J
Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
[TBL] [Abstract][Full Text] [Related]
55. The effectiveness of harm reduction in preventing HIV among injecting drug users.
Wodak A; Maher L
N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
[TBL] [Abstract][Full Text] [Related]
56. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
Barrio G; Bravo MJ; Brugal MT; Díez M; Regidor E; Belza MJ; de la Fuente L;
Addiction; 2012 Jun; 107(6):1111-22. PubMed ID: 22151686
[TBL] [Abstract][Full Text] [Related]
57. Drugs and Iran after the Islamic revolution: prophesying the next quarter century.
Spencer C; Agahi C
Int J Addict; 1990-1991; 25(2A):171-8; discussion 178-9. PubMed ID: 2269552
[TBL] [Abstract][Full Text] [Related]
58. The role and development of the Asian Harm Reduction Network.
Tanguay PF; Smits T
Int J Drug Policy; 2007 Mar; 18(2):148-51. PubMed ID: 17689359
[TBL] [Abstract][Full Text] [Related]
59. Harm reduction as a complex adaptive system: A dynamic framework for analyzing Tanzanian policies concerning heroin use.
Ratliff EA; Kaduri P; Masao F; Mbwambo JK; McCurdy SA
Int J Drug Policy; 2016 Apr; 30():7-16. PubMed ID: 26790689
[TBL] [Abstract][Full Text] [Related]
60. Rapid scale up of harm reduction in China.
Sullivan SG; Wu Z
Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
